Filtros de búsqueda

Lista de obras de Pier Luigi Zinzani

18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma

artículo científico publicado en 2006

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

90 Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) - The Zeno Study

scientific article published on 13 January 2020

90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years

scientific article published on 14 March 2016

A 3-decade multicenter European experience with cladribine as upfront treatment in 384 patients with hairy cell leukemia

artículo científico publicado en 2022

A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

artículo científico publicado en 2017

A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies

artículo científico publicado en 2019

A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma

artículo científico publicado en 2012

A patient with plasmablastic lymphoma achieving long-term complete remission after thalidomide-dexamethasone induction and double autologous stem cell transplantation: a case report.

artículo científico publicado en 2018

A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma

artículo científico publicado en 2008

A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients

artículo científico publicado en 2016

A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients.

artículo científico publicado en 2008

A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma

artículo científico publicado en 2011

A retrospective international study on primary extranodal marginal zone lymphoma of the lung (BALT lymphoma) on behalf of International Extranodal Lymphoma Study Group (IELSG).

artículo científico publicado en 2015

A treatment for activated B-cell-like DLBCL?

ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned

artículo científico publicado en 2011

ALCL: is it now a curable disease?

artículo científico publicado en 2017

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial.

artículo científico publicado en 2017

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial ⬇️

artículo científico publicado el 2 de octubre de 2010

Advances in management of follicular lymphoma

artículo científico publicado en 2014

Aggressive lymphoma: improving treatment outcome with rituximab.

artículo científico publicado en 2002

Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients

artículo científico publicado en 2012

An isolated penile mass in a young adult turned out to be a primary marginal zone lymphoma of the penis. A case report and a review of literature

artículo científico publicado en 2013

An open-label, multicohort Phase Ib trial of pembrolizumab (MK-3475) for advanced hematologic malignancies: KEYNOTE-013.

artículo científico publicado en 2015

Angioimmunoblastic T-Cell Lymphoma

artículo científico publicado en 2017

Appropriate use of bendamustine in first-line therapy of chronic lymphocytic leukemia. Recommendations from SIE, SIES, GITMO Group.

artículo científico publicado en 2014

Are Biosimilars the Future of Oncology and Haematology?

scientific article published on 01 October 2019

Association of essential thrombocythemia and non-Hodgkin lymphoma: a single-centre experience.

artículo científico publicado en 2009

Autologous hematopoietic stem cell transplantation in Non-Hodgkin's lymphomas

artículo científico publicado en 2005

B cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: role of ZAP70 determination on bone marrow biopsy specimens

artículo científico publicado en 2006

BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia

artículo científico publicado en 2019

Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin

artículo científico publicado en 2013

Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL).

artículo científico publicado en 2012

Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients

artículo científico publicado en 2020

Bendamustine: role and evidence in lymphoma therapy, an overview

artículo científico

Bilateral orbital Erdheim-Chester disease treated with 12 weekly administrations of VNCOP-B chemotherapy: a case report and a review of literature

artículo científico publicado en 2011

Bilateral primary breast lymphoma: a case of local recurrence

scientific article published on 01 April 2003

Biology and treatment of follicular lymphoma

scientific article published on October 2009

Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study

artículo científico publicado en 2012

Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial

artículo científico publicado en 2011

Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trial

artículo científico publicado en 2012

Brentuximab Vedotin in CD30-Positive Lymphomas: A SIE, SIES, and GITMO Position Paper

artículo científico

Brentuximab Vedotin in Transplant-Naïve Relapsed/Refractory Hodgkin Lymphoma: Experience in 30 Patients

artículo científico publicado en 2015

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma

artículo científico publicado en 2017

Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study.

artículo científico publicado en 2015

Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial

artículo científico publicado en 2017

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma: An updated review of published data from the named patient program

artículo científico publicado en 2016

Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials

artículo científico publicado en 2013

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

artículo científico publicado en 2017

Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial

Bronchus-associated lymphoid tissue lymphomas: an update of a rare extranodal maltoma

artículo científico publicado en 2007

CD30 expression in peripheral T-cell lymphomas

artículo científico publicado en 2013

CDKN1B/p27 expression in peripheral T cell lymphoma not otherwise specified.

artículo científico publicado en 2010

CNS recurrence of primary mediastinal large b-cell lymphoma after complete remission

artículo científico publicado en 2009

Challenging CD30-positive lymphomas--current challenges, new insights and future directions: joining a conversation on CD30+ lymphomas

artículo científico publicado en 2014

Challenging paradigms in lymphoma treatment.

artículo científico publicado en 2004

Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients.

artículo científico publicado en 2014

Chronic lymphocytic leukemia focus in the context of a cardiac mass in a pretreated patient: an exceptional incidental finding

artículo científico publicado en 2020

Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up

scientific article published on 10 March 2009

Clinical Features and Treatment Outcomes of Primary Cutaneous B-cell Lymphomas: A Thirty-year Experience

artículo científico publicado en 2018

Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG).

artículo científico publicado en 2010

Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group

artículo científico publicado en 2014

Clinical experience with fludarabine in indolent non-Hodgkin's lymphoma

artículo científico publicado en 2004

Clinical significance of axillary findings in patients with lymphoma during follow-up with 18F-fluorodeoxyglucose-PET.

artículo científico publicado en 2008

Collection of hematopoietic stem cells after previous radioimmunotherapy is feasible and does not impair engraftment after autologous stem cell transplantation in follicular lymphoma.

artículo científico publicado en 2013

Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials.

artículo científico publicado en 2016

Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial

artículo científico publicado en 2011

Complete response of relapsed systemic and cutaneous anaplastic large cell lymphoma using brentuximab vedotin: 2 case reports

artículo científico publicado en 2013

Complications of cytotoxic chemotherapy in older patients: focus on myelotoxicity in lymphomas ⬇️

artículo científico publicado el 15 de octubre de 2003

Consensus conference on the management of tumor lysis syndrome

scientific article published on 06 October 2008

Consensus conference on the use of 90-yttrium-ibritumomab tiuxetan therapy in clinical practice. A project of the Italian society of hematology

artículo científico publicado en 2010

Consensus conference: implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - report of a European workshop

artículo científico publicado en 2008

Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia

artículo científico publicado en 2016

Consensus-based definition of unfitness to intensive and non-intensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy decision making

artículo científico publicado en 2013

Consistency of FDG-PET accuracy and cost-effectiveness in initial staging of patients with Hodgkin lymphoma across jurisdictions

scientific article published on 01 August 2011

Consolidation with 90Y ibritumomab tiuxetan radioimmunotherapy in mantle cell lymphoma patients ineligible for high dose therapy: results of the phase II multicentre Polish Lymphoma Research Group trial, after 8-year long follow-up.

artículo científico publicado en 2019

Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma

artículo científico publicado en 2015

Continuous infusion of interleukin-2 in two relapsed high grade non-Hodgkin lymphoma patients: Effectiveness and tolerability ⬇️

artículo científico publicado el 1 de enero de 1991

Copanlisib in patients with relapsed or refractory follicular lymphoma

Critical concepts, practice recommendations, and research perspectives of pixantrone therapy in non-Hodgkin lymphoma: a SIE, SIES, and GITMO consensus paper

artículo científico publicado en 2016

Critical value of laparotomy with splenectomy in Stage III Hodgkin's disease as restaging procedure after chemotherapy ⬇️

artículo científico publicado el 1 de julio de 1988

Cutaneous T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease.

artículo científico publicado en 2017

Cutaneous leukocytoclastic vasculitis in B-cell chronic lymphocytic leukaemia patients

artículo científico publicado en 2018

Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma

artículo científico publicado en 2009

DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma

artículo científico publicado en 2019

Diagnostic accuracy of positron emission tomography/computed tomography-driven biopsy for the diagnosis of lymphoma

scientific article published on 15 June 2020

Difficult diagnostic and therapeutic cases: CASE 1. true thymic hyperplasia in a patient treated for T-cell lymphoma.

artículo científico publicado en 2004

Diffuse large B-cell lymphoma (DLBCL), anaplastic variant. report on a problematic case primarily arising in the stomach

scientific article published on 01 December 2002

Discordant response to chemotherapy: An unusual patternof fluoro-deoxy-d-glucose uptake in heavily pre-treated lymphoma patients

artículo científico publicado en 2006

Dissection of DLBCL Microenvironment Provides a Gene Expression-Based Predictor of Survival Applicable to Formalin-Fixed Paraffin-Embedded Tissue

article

Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia

artículo científico publicado en 2021

Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma

artículo científico publicado en 2019

ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma.

artículo científico publicado en 2013

EXTEND PIX301: a phase III randomized trial of pixantrone versus other chemotherapeutic agents as third-line monotherapy in patients with relapsed, aggressive non-Hodgkin's lymphoma.

artículo científico publicado en 2006

Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial

artículo científico publicado en 2003

Early interim 18F-FDG PET in Hodgkin's lymphoma: evaluation on 304 patients

article by Pier Luigi Zinzani et al published January 2012 in European Journal of Nuclear Medicine and Molecular Imaging

Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients.

artículo científico publicado en 2006

Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET.

artículo científico publicado en 2008

Effectiveness of chemotherapy after anti-PD-1 blockade failure for relapsed and refractory Hodgkin lymphoma

scientific article published on 02 September 2020

Effectiveness of fludarabine, idarubicin and cyclophosphamide (FLUIC) combination regimen for young patients with untreated non-follicular low-grade non-Hodgkin's lymphoma

artículo científico publicado en 2004

Efficacy and safety of biosimilar epoetin alpha in patients with chronic lymphoid neoplasms and chemotherapy-induced anaemia: An observational, retrospective, monocentric analysis

artículo científico publicado en 2017

Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study

artículo científico publicado en 2016

Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas

artículo científico publicado en 2005

Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem-cell transplantation

artículo científico publicado en 2007

Efficacy of idelalisib as bridge to allogeneic stem cell transplant in relapsed follicular lymphoma: a case report

artículo científico publicado en 2017

Enteropathy-associated T-cell lymphoma

artículo científico publicado en 2010

Erythroderma and non-Hodgkin T-cell lymphoma: what else, apart from Mycosis Fungoides and Sézary syndrome?

artículo científico publicado en 2016

Erythrophagocytosis by neoplastic cells in a patient with myelodysplastic syndrome

artículo científico publicado en 2004

European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma.

artículo científico publicado en 2016

Experience of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma and relapsed/refractory systemic anaplastic large-cell lymphoma in the Named Patient Program: Review of the literature

artículo científico

Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms

artículo científico publicado en 2003

Expression of CD52 in peripheral T-cell lymphoma

artículo científico publicado en 2007

Expression of platelet-derived growth factor receptor alpha in peripheral T-cell lymphoma not otherwise specified

scientific article published on 01 June 2005

Extramedullary myeloid tumour of the stomach and duodenum presenting without acute myeloblastic leukemia: A diagnostic and therapeutic challenge

scientific article published on 01 January 2008

Extranodal marginal zone B-cell lymphoma of MALT-type of the lung: single-center experience with 12 patients

artículo científico publicado en 2003

Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens

artículo científico publicado en 2012

FDG PET/CT predictive role in follicular lymphoma.

artículo científico publicado en 2012

FMP regimen (fludarabine, mitoxantrone, prednisone) as therapy in recurrent low‐grade non‐Hodgkin's lymphoma ⬇️

artículo científico publicado el 1 de octubre de 1995

Finalization of autologous stem cell transplant in complex and multirelapsed follicular lymphoma

scientific article published on 22 May 2020

Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).

artículo científico publicado en 2008

Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease

artículo científico publicado en 2011

Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma

artículo científico publicado en 2004

Fludarabine treatment in resistant Waldenstrom's macroglobulinemia ⬇️

artículo científico publicado el 1 de febrero de 1995

Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patients

article

Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma

artículo científico publicado en 2004

Fludarabine-mitoxantrone combination-containing regimen in recurrent low-grade non-Hodgkin's lymphoma ⬇️

artículo científico publicado el 1 de abril de 1997

Fludarabine-mitoxantrone-rituximab regimen in untreated intermediate/high-risk follicular non-Hodgkin's lymphoma: experience on 142 patients.

artículo científico publicado en 2013

From chronic lymphocytic leukemia to Hodgkin's disease: a case of prognostically favorable transformation

scientific article published on 01 August 2002

GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers.

artículo científico publicado en 2012

Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients

artículo científico publicado en 2005

Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome.

artículo científico publicado en 2009

Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation

article

Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets

artículo científico publicado en 2007

Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas

article

Genomic imbalances associated with secondary acute leukemias in Hodgkin lymphoma

artículo científico publicado en 2007

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium

artículo científico publicado en 2019

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium

artículo científico publicado en 2017

Granulomatous tattoo reaction in a nivolumab-treated patient

Hairy cell leukemia and COVID-19 adaptation of treatment guidelines

artículo científico publicado en 2021

Hairy cell leukemia: allogeneic transplantation could be an optimal option in selected patients

Hairy cell leukemia: evaluation of the long-term outcome in 121 patients

artículo científico publicado en 2010

High efficacy of the MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis, a 20 year experience

artículo científico publicado en 2015

High-dose therapy and stem cell transplantation

scientific article published on April 2010

High-dose therapy with autologous transplantation for Hodgkin's disease: the Bologna experience

scientific article published on 01 May 2003

High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience

artículo científico publicado en 2004

Higher response to lenalidomide in relapsed/refractory diffuse large B-cell lymphoma in nongerminal center B-cell-like than in germinal center B-cell-like phenotype.

artículo científico publicado en 2011

Histological findings in patients with suspected mediastinal lymphoma relapse according to positive positron emission tomography scan during follow-up: a large retrospective analysis in 96 patients

scientific article published on 01 March 2019

Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma.

artículo científico publicado en 2007

Histopathology of B-cell chronic lymphocytic leukemia.

artículo científico publicado en 2004

Hodgkin lymphoma presenting with paraneoplastic myasthenia: a case report

artículo científico publicado en 2018

Idelalisib as a Bridge to Allogeneic Transplantation in Relapsed/Refractory Lymphoma With Renal Cancer: A Case Report

artículo científico publicado en 2019

Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays

artículo científico publicado en 2005

Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients.

artículo científico publicado en 2002

Immunophenotype and intermediate-high international prognostic index score are prognostic factors for therapy in diffuse large B-cell lymphoma patients

artículo científico publicado en 2010

Impressive Response to Pixantrone after Allogeneic Transplant in a Multiple Relapsed Diffuse Large B-Cell Lymphoma.

artículo científico publicado en 2017

Impressive response to pegylated liposomal doxorubicin after allogeneic transplantation in a multi-relapsed Hodgkin's lymphoma

artículo científico publicado en 2014

In Reply

In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia

artículo científico publicado en 2015

In vivo treatment sensitivity testing with positron emission tomography/computed tomography after one cycle of chemotherapy for Hodgkin lymphoma

artículo científico publicado en 2014

Indolent lymphoma: the pathologist's viewpoint.

artículo científico publicado en 2004

Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients

artículo científico publicado en 2002

Infection control in patients treated for chronic lymphocytic leukemia with ibrutinib or idelalisib: recommendations from Italian society of hematology

scientific article published on 02 May 2019

Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease

artículo científico publicado en 2020

Integrating precision medicine through evaluation of cell of origin in treatment planning for diffuse large B-cell lymphoma

artículo científico publicado en 2019

Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma

artículo científico publicado en 2019

Interesting activity of pegylated liposomal doxorubicin in primary refractory and multirelapsed Hodgkin lymphoma patients: bridge to transplant.

artículo científico publicado en 2018

Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study.

artículo científico publicado en 2016

International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).

artículo científico publicado en 2017

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

artículo científico publicado en 2018

Is it really possible to cure hairy cell leukemia patients only with frontline therapy?

artículo científico publicado en 2014

Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation guidelines for the management of indolent, nonfollicular B-cell lymphoma (marginal zone, lymphoplasmacytic, and small lympho

artículo científico publicado en 2014

Italian expert panel consensus statement on the optimal use of PD-1 blockade therapy in classical Hodgkin lymphoma

article

Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphoma

artículo científico publicado en 2017

Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma.

artículo científico publicado en 2018

Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma

artículo científico publicado en 2017

Late FDG PET normalization after radioimmunotherapy in a patient with non-Hodgkin lymphoma.

artículo científico publicado en 2009

Lenalidomide Combination Therapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma: The Italian Real-Life Experience

artículo científico publicado en 2019

Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study).

artículo científico publicado en 2018

Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice

artículo científico publicado en 2019

Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified

scientific article published on 19 April 2011

Lenalidomide monotherapy in heavily pretreated patients with non-Hodgkin lymphoma: an Italian observational multicenter retrospective study in daily clinical practice.

artículo científico publicado en 2014

Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.

artículo científico publicado en 2004

Leukocytoclastic vasculitis associated with hairy cell leukemia at diagnosis: a case report and review of the literature.

artículo científico publicado en 2016

Local versus systemic treatment for primary cutaneous B-cell lymphoma

artículo científico publicado en 2010

Long-Term Responders After Brentuximab Vedotin: Single-Center Experience on Relapsed and Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients

artículo científico publicado en 2016

Long-term analysis of phase II studies of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma.

artículo científico publicado en 2017

Long-term efficacy of the combination of lenalidomide and rituximab in elderly relapsed/refractory diffuse large B-cell lymphoma patients.

artículo científico publicado en 2013

Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study

artículo científico publicado en 2022

Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine.

artículo científico publicado en 2004

Long-term follow-up of lenalidomide in relapsed/refractory mantle cell lymphoma: subset analysis of the NHL-003 study

artículo científico publicado en 2013

Long-term follow-up studies in hairy cell leukemia

scientific article published on October 2009

Long-term outcome of patients with advanced-stage cutaneous T cell lymphoma treated with gemcitabine.

artículo científico publicado en 2014

Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials

artículo científico publicado en 2020

Long-term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2-year follow-up of the CHRONOS-1 study

artículo científico publicado en 2019

Loxoribine Affects Fludarabine Activity on Freshly Isolated B-chronic Lymphocytic Leukemia Cells ⬇️

artículo científico publicado el 1 de julio de 1997

Lymphoma: diagnosis, staging, natural history, and treatment strategies

artículo científico publicado en 2005

Lymphoproliferative Lung Disorders

Lymphoproliferative lung disorders

artículo científico publicado en 2005

MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients.

artículo científico publicado en 2009

MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients

artículo científico publicado en 2018

Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma

artículo científico publicado en 2018

Management of adverse events associated with idelalisib treatment in chronic lymphocytic leukemia and follicular lymphoma: A multidisciplinary position paper

artículo científico publicado en 2019

Management of central nervous system relapse in a young patient affected by primary mediastinal large B-cell lymphoma: A case report

artículo científico publicado en 2020

Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation

artículo científico publicado en 2006

Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.

artículo científico publicado en 2006

Management of nodal indolent (non marginal-zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow Transplantation

artículo científico publicado en 2005

Management of relapsed/refractory mantle cell lymphoma: a review of current therapeutic strategies.

artículo científico

Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score

artículo científico publicado en 2006

Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma.

artículo científico publicado en 2018

Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma

artículo científico publicado en 2010

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

artículo científico publicado en 2018

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia

artículo científico publicado en 2015

Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study.

artículo científico publicado en 2013

Monotherapy with pixantrone in histologically confirmed relapsed or refractory aggressive B-cell non-Hodgkin lymphoma: post-hoc analyses from a phase III trial

scientific article published on 26 April 2016

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

scholarly article by Robert J Kreitman et al published August 2018 in Leukemia

Multicenter phase II trial of immunotherapy with the humanized anti-CD22 antibody, epratuzumab, in combination with rituximab, in refractory or recurrent non-Hodgkin's lymphoma

artículo científico publicado en 2006

Multisystemic and Multiresistant Langerhans Cell Histiocytosis: A Case Treated With BRAF Inhibitor.

artículo científico publicado en 2015

Mycosis fungoides

artículo científico publicado en 2007

Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients

article

New therapies and old side-effects in mycosis fungoides treatment: brentuximab vedotin-induced alopecia

artículo científico publicado en 2019

Nivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase II CheckMate 436 Study

scientific article published on 09 August 2019

Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial

article

Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial

artículo científico publicado en 2016

Nodal marginal-zone lymphoma associated with monoclonal light-chain and heavy-chain deposition disease.

artículo científico publicado en 2004

Non-Hodgkin's lymphoma: the evolving role of purine analogues

artículo científico publicado en 2002

Non-hodgkin lymphomas presenting as soft tissue masses: a single center experience and meta-analysis of the published series.

artículo científico

Non-peghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity

artículo científico publicado en 2020

Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue

artículo científico publicado en 2002

Novel Methods to Improve the Efficiency of Radioimmunotherapy for Non-Hodgkin Lymphoma

scientific article published on 31 March 2019

Novel therapies for aggressive B-cell lymphoma

artículo científico publicado en 2012

Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin Lymphomas

artículo científico publicado en 2018

Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel - an update

artículo científico publicado en 2015

Optimizing Outcomes in Primary Mediastinal B-cell Lymphoma

artículo científico publicado en 2016

Outpatient experience with biosimilar filgrastim in patients with lymphoid neoplasm: Lessons from daily clinical practice

artículo científico publicado en 2016

Overview of alemtuzumab therapy for the treatment of T-cell lymphomas

artículo científico publicado en 2011

PD-1 blockade as bridge to allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphoma patients: a retrospective single center case series

artículo científico publicado en 2019

PET in T-Cell Lymphoma.

artículo científico publicado en 2011

PET in natural killer/T-cell lymphoma: the debate continues.

artículo científico publicado en 2015

PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma

artículo científico publicado en 2014

Panobinostat in patients with relapsed/refractory Hodgkin's lymphoma after autologous stem-cell transplantation: results of a phase II study

artículo científico publicado en 2012

Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Cutaneous T-cell lymphomas

artículo científico publicado en 2016

Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Peripheral T-cell lymphomas

artículo científico publicado en 2016

Pathobiology of primary mediastinal B-cell lymphoma

artículo científico publicado en 2003

Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma

scientific article published on 23 April 2019

Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087

scientific article published on 13 August 2019

Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies.

scientific article published on 28 August 2008

Peripheral T cell lymphomas: from the bench to the clinic

scientific article published on 06 April 2020

Peripheral T-cell lymphoma

artículo científico publicado en 2011

Peripheral T-cell lymphoma, not otherwise specified

artículo científico publicado en 2017

Peripheral T-cell lymphoma--not otherwise specified

artículo científico publicado en 2010

Peripheral T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease.

artículo científico publicado en 2017

Peripheral T-cell lymphomas: in "real life" experience are we really improving?

artículo científico publicado en 2013

Persistent agmination of lymphomatoid papulosis: an ongoing debate.

artículo científico

Pharmacogenetics and proteomics of anticancer drugs in non-Hodgkin's lymphoma.

artículo científico publicado en 2003

Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization.

artículo científico publicado en 2008

Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphoma

artículo científico publicado en 2007

Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma

artículo científico publicado en 2017

Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB-IVA mycosis fungoides/Sézary syndrome.

artículo científico publicado en 2016

Phase II study of pembrolizumab (MK-3475) for relapsed/refractory classical Hodgkin Lymphoma (r/r cHL): keynote-087.

artículo científico publicado en 2015

Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma

artículo científico publicado en 2007

Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients

artículo científico publicado en 2010

Phase II trial of temozolomide in patients with pretreated cutaneous T-cell lymphoma.

artículo científico publicado en 2005

Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma

artículo científico publicado en 2008

Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.

artículo científico publicado en 2018

Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma

artículo científico publicado en 2017

Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial

artículo científico publicado en 2012

Plaques and tumors in a patient with refractory Sézary syndrome treated with mogamulizumab

artículo científico publicado en 2018

Plaques und Tumoren unter der Therapie mit Mogamulizumab bei einer Patientin mit refraktärem Sézary-Syndrom

artículo científico publicado en 2018

Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway.

artículo científico publicado en 2014

Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS)

scientific article published on 29 March 2019

Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma

artículo científico publicado en 2016

Possible novel agents in marginal zone lymphoma

artículo científico publicado en 2016

Posttransplant lymphoproliferative disorders in liver transplanted patients: a report of four cases

artículo científico publicado en 2006

Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation.

artículo científico publicado en 2005

Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: a real-life experience

scientific article published on 09 September 2020

Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding.

artículo científico publicado en 2018

Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental H

artículo científico publicado en 2008

Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study

artículo científico publicado en 2011

Pralatrexate is synergistic with the proteasome inhibitor bortezomib in in vitro and in vivo models of T-cell lymphoid malignancies

artículo científico publicado en 2010

Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients

artículo científico publicado en 2004

Predictive role of positron emission tomography in the outcome of patients with follicular lymphoma.

artículo científico publicado en 2007

Preliminary observations of a phase II study of reduced-dose alemtuzumab treatment in patients with pretreated T-cell lymphoma

artículo científico publicado en 2005

Prespecified candidate biomarkers identify follicular lymphoma patients who achieved longer progression-free survival with bortezomib-rituximab versus rituximab.

artículo científico

Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma

artículo científico publicado en 2008

Prevention of large-scale implementation of unnecessary and expensive predictive tests in Hodgkin's lymphoma - Authors' reply.

artículo científico publicado en 2017

Primary bone lymphoma: evaluation of chemoimmunotherapy as front-line treatment in 21 patients

scientific article published on 07 May 2011

Primary bone lymphoma: experience with 52 patients

artículo científico publicado en 2003

Primary cardiac non-Hodgkin lymphoma presenting with atrial flutter and pericardial effusion.

artículo científico publicado en 2006

Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers.

artículo científico publicado en 2016

Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

artículo científico publicado en 2018

Primary cutaneous peripheral T-cell lymphoma not otherwise specified a rare and aggressive lymphoma

artículo científico publicado en 2018

Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group

scientific article published on 01 July 2009

Primary gastric diffuse large-cell lymphoma

artículo científico publicado en 2006

Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins

artículo científico publicado en 2003

Primary mediastinal DLBCL: evolving biologic understanding and therapeutic strategies

artículo científico

Primary non-Hodgkin's lymphoma of the bone: treatment and analysis of prognostic factors for Stage I and Stage II

article

Primary ocular adnexal lymphomas: a retrospective study of 25 patients.

artículo científico publicado en 2013

Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas

article

Prognostic models for primary mediastinal (thymic) B-cell lymphoma derived from 18-FDG PET/CT quantitative parameters in the International Extranodal Lymphoma Study Group (IELSG) 26 study.

artículo científico publicado en 2017

Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial G

article

Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphoma.

artículo científico publicado en 2014

Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure

artículo científico publicado en 2016

Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays.

artículo científico publicado en 2011

Prolonged disease-free survival in elderly relapsed diffuse large B-cell lymphoma patients treated with lenalidomide plus rituximab

artículo científico publicado en 2016

Quantitative PCR of bone marrow BCL2/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma

artículo científico publicado en 2005

RALE051: a novel established cell line of sporadic Burkitt lymphoma

artículo científico publicado en 2017

Radioimmunotherapy (RIT) for Follicular Lymphoma achieves long term lymphoma control in first line and at relapse: 8-year follow-up data of 281 patients from the international RIT-registry

scientific article published on 04 December 2018

Radioimmunotherapy as the first line of treatment in non-Hodgkin lymphoma.

artículo científico publicado en 2018

Radioimmunotherapy confers long-term survival to lymphoma patients with acceptable toxicity: registry analysis by the International Radioimmunotherapy Network

artículo científico publicado en 2011

Radioimmunotherapy for Mantle Cell Lymphoma: 5-Year Follow-up of 90 Patients from the International RIT-Registry

Radioimmunotherapy for first-line and relapse treatment of aggressive B-cell non-Hodgkin lymphoma: an analysis of 215 patients registered in the international RIT-Network

artículo científico publicado en 2014

Radioimmunotherapy with (90)Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-Network.

artículo científico publicado en 2010

Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study

artículo científico publicado en 2015

Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

artículo científico publicado en 2019

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.

artículo científico publicado en 2019

Reactive follicular lymphoid infiltrate: a new condition to exclude in patients with PET positivity inside the heart.

artículo científico publicado en 2014

Recurrent Hodgkin lymphoma: toward a new definition of candidates for autologous stem cell transplant in the era of positron emission tomography scan and novel agents.

artículo científico publicado en 2014

Reduced hematologic response to alpha-interferon therapy in patients with hairy cell leukemia showing a peculiar immunologic phenotype ⬇️

artículo científico publicado el 15 de mayo de 1990

Reporting real-life experience with drugs in lymphoma patients

artículo científico publicado en 2016

Results from a Phase I/II Open-Label, Dose-Finding Study of Pralatrexate and Oral Bexarotene in Patients with Relapsed/Refractory Cutaneous T-cell Lymphoma.

artículo científico publicado en 2017

Results in hairy-cell leukemia patients treated with alpha-interferon: predictive prognostic factors

artículo científico publicado el 1 de septiembre de 1992

Risk of second cancer in patients with hairy cell leukemia: long-term follow-up

artículo científico

Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study

artículo científico publicado en 2009

Rituximab in heavily pretreated cutaneous B-cell lymphoma

artículo científico publicado en 2003

Rituximab in primary conjunctiva lymphoma

artículo científico publicado en 2005

Role of 18F-FLT PET/CT in suspected recurrent or residual lymphoma: final results of a pilot prospective trial

scientific article published on 17 May 2019

Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma

artículo científico publicado en 2009

Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy

Role of autologous stem cell transplantation in T-cell lymphoma patients: a single institution retrospective analysis

artículo científico publicado en 2014

Role of interferon-alpha administration after 2-deoxycoformycin in the treatment of hairy cell leukemia patients.

artículo científico publicado en 2006

Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient program.

artículo científico publicado en 2016

SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma

artículo científico publicado en 2013

SIE, SIES, GITMO updated clinical recommendations for the management of chronic lymphocytic leukemia

artículo científico publicado en 2011

SIE-SIES-GITMO guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias.

artículo científico publicado en 2014

Safety and efficacy of (90) yttrium-ibritumomab-tiuxetan for untreated follicular lymphoma patients. An Italian cooperative study

artículo científico publicado en 2013

Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma.

artículo científico publicado en 2017

Safety and efficacy of single-agent bendamustine after failure of brentuximab vedotin in patients with relapsed or refractory hodgkin's lymphoma: experience with 27 patients

artículo científico publicado en 2015

Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma.

artículo científico publicado en 2017

Salvage chemotherapy in follicular non-Hodgkin's lymphoma: focus on tolerability

artículo científico publicado en 2006

Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remi

scientific article published on 18 April 2014

Serum soluble interleukin-2 receptor levels in hairy cell leukemia: correlation with clinical and hematological parameters and with alpha-interferon treatment

artículo científico publicado el 1 de mayo de 1992

Severe peripheral motor neuropathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin

article

Siltuximab in relapsed/refractory multicentric Castleman disease: Experience of the Italian NPP program

article

Single-agent lenalidomide is active in patients with relapsed or refractory aggressive non-Hodgkin lymphoma who received prior stem cell transplantation

artículo científico publicado en 2013

Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient

artículo científico publicado en 2014

Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi

artículo científico publicado en 2018

Spontaneous remission of follicular lymphoma

scientific article published on 18 August 2019

Successful Employment of Brentuximab Vedotin in a Patient Undergoing Hemodialysis: The First Real-life Experience

artículo científico publicado en 2019

Successful stem cell harvest and autologous transplantation in a patient with cold agglutinin syndrome and aggressive lymphoma

artículo científico publicado en 2020

Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre study

article

T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication

artículo científico publicado en 2002

T-cell lymphomas in South america and europe

artículo científico publicado en 2012

Targeted molecular therapy in peripheral T-cell lymphomas

artículo científico publicado en 2011

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia

artículo científico publicado en 2015

The Berlin-Frankfurt-Münster protocol for the upfront treatment of aggressive lymphomas: The Bologna experience

artículo científico publicado en 2018

The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients

artículo científico publicado en 2018

The clinical value of tumor burden at diagnosis in Hodgkin lymphoma

scientific article published on 01 October 2004

The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphoma

artículo científico publicado en 2015

The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.

artículo científico publicado en 2016

The conjugate Rituximab/saporin-S6 completely inhibits clonogenic growth of CD20-expressing cells and produces a synergistic toxic effect with Fludarabine.

artículo científico publicado en 2004

The development of more than one histologic type of lymphoma in the same patient is frequent and confers a worse prognosis

article

The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non-Hodgkin lymphoma of distinct histological origin

artículo científico publicado en 2011

The efficacy of lenalidomide combination therapy in heavily pretreated non-Hodgkin lymphoma patients: an Italian observational, multicenter, retrospective study.

artículo científico publicado en 2016

The emerging role of GSK-3β in the pathobiology of classical Hodgkin lymphoma

artículo científico publicado en 2017

The first International Workshop on Non-Hodgkin's Lymphoma: taking a close look at current issues and future developments

artículo científico publicado en 2003

The importance of assessing blood tumour burden in cutaneous T-cell lymphoma

artículo científico publicado en 2020

The landscape of new drugs in lymphoma

artículo científico publicado en 2016

The many faces of marginal zone lymphoma

artículo científico

The modified International Prognostic Index can predict the outcome of localized primary intestinal lymphoma of both extranodal marginal zone B-cell and diffuse large B-cell histologies

artículo científico publicado en 2002

The more patients you treat, the more you cure: managing cardiotoxicity in the treatment of aggressive non-Hodgkin lymphoma

artículo científico publicado en 2014

The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL).

artículo científico publicado en 2014

The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL).

artículo científico

The role of anthracyclines in combination chemotherapy for the treatment of follicular lymphoma: retrospective study of the Intergruppo Italiano Linfomi on 761 cases

artículo científico publicado en 2003

The role of mitoxantrone in the treatment of indolent lymphomas.

artículo científico publicado en 2005

The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patients.

artículo científico publicado en 2014

The role of transplantation in Hodgkin lymphoma

artículo científico publicado en 2018

The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30‐year experience

artículo científico publicado en 2021

The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients

artículo científico publicado en 2017

The unique biology and treatment of primary mediastinal B-cell lymphoma

artículo científico publicado en 2018

The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi.

artículo científico publicado en 2013

Therapeutic implications of intratumor heterogeneity for TP53 mutational status in Burkitt lymphoma.

artículo científico publicado en 2015

Therapeutic options in relapsed or refractory peripheral T-cell lymphoma

artículo científico

Thoughts on the eradication of Helicobacter pylori infection in localized gastric mucosa-associated lymphoid tissue lymphoma

article

Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas

artículo científico publicado en 2012

Traditional treatment approaches in B-cell non-Hodgkin's lymphoma

artículo científico publicado en 2003

Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations.

artículo científico publicado en 2017

Understanding the group of peripheral T-cell lymphomas, unspecified.

artículo científico publicado en 2005

Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma

artículo científico publicado en 2015

Utility of surgical resection with or without radiation therapy in patients with low-grade gastric mucosa-associated lymphoid tissue lymphoma

scientific article published on 01 July 2003

VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly

artículo científico publicado en 2007

Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphoma

artículo científico publicado en 2005

Vemurafenib mucosal side-effect

artículo científico publicado en 2015

Waldenstrom's macroglobulinemia: is there a place and time for a cease-fire?

artículo científico publicado en 2003

Yttrium-90 ibritumomab tiuxetan as a single agent in patients with pretreated B-cell lymphoma: evaluation of the long-term outcome

scientific article published on 01 August 2010

[18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.

artículo científico

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda